MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-11-2026
SCYNEXIS Operating Cycle 2011-2026 | SCYX
Annual Operating Cycle SCYNEXIS
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 2.74 | 106 | 11.9 | - | - | - | - | - | - | 33.1 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 106 | 2.74 | 38.5 |
Quarterly Operating Cycle SCYNEXIS
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 119 | 1.53 | 168 | - | 138 | 132 | 165 | - | 2.56 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 485 | 35.5 | - | 35 | 30.2 | 25.6 | - | 28 | 27.3 | 11 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 485 | 1.53 | 93.6 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
662 | $ 5.66 | 0.98 % | $ 84.1 M | USA |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
117 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
653 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
61.7 | $ 2.72 | 1.49 % | $ 1.04 B | Canada |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
153 | $ 38.34 | 1.86 % | $ 1.41 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.03 | 3.01 % | $ 111 M | Canada |
 |
Organogenesis Holdings
ORGO
|
106 | $ 2.42 | 3.21 % | $ 307 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 23.0 | 0.04 % | $ 1.06 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 1.12 | 2.75 % | $ 1.39 M | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.17 | 4.11 % | $ 174 M | Canada |
 |
Jupiter Wellness
JUPW
|
132 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.07 | 0.47 % | $ 102 M | Canada |
 |
Tilray
TLRY
|
222 | $ 5.14 | 3.21 % | $ 3.18 B | Canada |
 |
cbdMD
YCBD
|
152 | $ 0.71 | 3.49 % | $ 2.86 M | USA |
 |
Evolus
EOLS
|
134 | $ 6.68 | -0.74 % | $ 431 M | USA |
 |
Emergent BioSolutions
EBS
|
425 | $ 8.41 | 1.08 % | $ 450 M | USA |
 |
Veru
VERU
|
271 | $ 3.05 | 1.61 % | $ 44.7 M | USA |
 |
Assertio Holdings
ASRT
|
590 | $ 23.49 | 0.02 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
982 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
239 | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
79.8 | $ 5.13 | 1.38 % | $ 1.9 B | Canada |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
601 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
113 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
221 | $ 16.43 | -0.27 % | $ 19.2 B | USA |
 |
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
14.6 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
72.5 | $ 0.64 | 2.32 % | $ 23 M | USA |
 |
China Pharma Holdings
CPHI
|
187 | $ 0.77 | 7.74 % | $ 3.3 M |  China |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 2.29 | 4.09 % | $ 26.5 M | USA |